Effects of COVID-19 on Arrhythmia

被引：14
作者：
Zhan, Yujia [1 ]
Yue, Honghua [1 ]
Liang, Weitao [1 ]
Wu, Zhong [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Cardiovasc Surg, Chengdu 610017, Peoples R China
来源：
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE | 2022年 / 9卷 / 09期
基金：
中国国家自然科学基金;
关键词：
COVID-19; SARS-CoV-2; arrhythmia; cardiovascular disease; coronavirus; DISEASE; 2019; COVID-19; ATRIAL-FIBRILLATION; MYOCARDIAL INJURY; CORONAVIRUS; SARS-COV-2; COMPLICATIONS; INFLAMMATION; INFECTION; DRUGS; WUHAN;
D O I：
10.3390/jcdd9090292
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The World Health Organization announced that COVID-19, with SARS-CoV-2 as its pathogen, had become a pandemic on 11 March 2020. Today, the global epidemic situation is still serious. With the development of research, cardiovascular injury in patients with COVID-19, such as arrhythmia, myocardial injury, and heart failure, is the second major symptom in addition to respiratory symptoms, and cardiovascular injury is related to the prognosis and mortality of patients. The incidence of arrhythmia in COVID-19 patients ranges from 10% to 20%. The potential mechanisms include viral infection-induced angiotensin-converting enzyme 2 expression change, myocarditis, cytokine storm, cardiac injury, electrophysiological effects, hypoxemia, myocardial strain, electrolyte abnormalities, intravascular volume imbalance, drug toxicities and interactions, and stress response caused by virus infection. COVID-19 complicated with arrhythmia needs to be accounted for and integrated in management. This article reviews the incidence, potential mechanisms, and related management measures of arrhythmia in COVID-19 patients.
引用
收藏
页数：22
相关论文
共 149 条
[1]   Assessment of COVID-19 Treatment containing both Hydroxychloroquine and Azithromycin: A natural clinical trial [J].
Abbas, Hassan M. ;
Al-Jumaili, Ali Azeez ;
Nassir, Kawthar F. ;
Al-Obaidy, Muhammed Waheeb ;
Al Jubouri, Adnan Mohammed ;
Dakhil, Basim Dhawi ;
Abdulelah, Mohammed Mahir ;
Al Khames, Qutaiba Ahmed .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (04)
[2]   Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study [J].
Ageno, Walter ;
De Candia, Erica ;
Iacoviello, Licia ;
Di Castelnuovo, Augusto .
THROMBOSIS RESEARCH, 2021, 203 :138-141
[3]   Amiodarone as a possible therapy for coronavirus infection [J].
Aimo, Alberto ;
Baritussio, Aldo ;
Emdin, Michele ;
Tascini, Carlo .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (12) :E16-E18
[4]   Prevalence of bradyarrhythmias needing pacing in COVID-19 [J].
Akhtar, Zaki ;
Leung, Lisa W. M. ;
Kontogiannis, Christos ;
Zuberi, Zia ;
Bajpai, Abhay ;
Sharma, Sumeet ;
Chen, Zhong ;
Beeton, Ian ;
Sohal, Manav ;
Gallagher, Mark M. .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2021, 44 (08) :1340-1346
[5]   Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial [J].
Aman, Jurjan ;
Duijvelaar, Erik ;
Botros, Liza ;
Kianzad, Azar ;
Schippers, Job R. ;
Smeele, Patrick J. ;
Azhang, Sara ;
Bartelink, Imke H. ;
Bayoumy, Ahmed A. ;
Bet, Pierre M. ;
Boersma, Wim ;
Bonta, Peter, I ;
Boomars, Karin A. T. ;
Bos, Lieuwe D. J. ;
Bragt, Job J. M. H. van ;
Braunstahl, Gert-Jan ;
Celant, Lucas R. ;
Eger, Katrien A. B. ;
Geelhoed, J. J. Miranda ;
Glabbeek, Yurika L. E. van ;
Grotjohan, Hans P. ;
Hagens, Laura A. ;
Happe, Chris M. ;
Hazes, Boaz D. ;
Heunks, Leo M. A. ;
Heuvel, Michel van den ;
Hoefsloot, Wouter ;
Hoek, Rianne J. A. ;
Hoekstra, Romke ;
Hofstee, Herman M. A. ;
Juffermans, Nicole P. ;
Kemper, E. Marleen ;
Kos, Renate ;
Kunst, Peter W. A. ;
Lammers, Ariana ;
Lee, Ivo van der ;
Lee, E. Laurien van der ;
Zee, Anke-Hilse Maitland-van der ;
Asam, Pearl F. M. Mau ;
Mieras, Adinda ;
Muller, Mirte ;
Neefjes, Elisabeth C. W. ;
Nossent, Esther J. ;
Oswald, Laurien M. A. ;
Overbeek, Maria J. ;
Pamplona, Carolina C. ;
Paternotte, Nienke ;
Pronk, Niels ;
Raaf, Michiel A. de ;
Raaij, Bas F. M. van .
LANCET RESPIRATORY MEDICINE, 2021, 9 (09) :957-968
[6]   Low-Dose Whole-Lung Irradiation for COVID-19 Pneumonia: Short Course Results [J].
Ameri, Ahmad ;
Rahnama, Nazanin ;
Bozorgmehr, Rama ;
Mokhtari, Majid ;
Farahbakhsh, Mohammad ;
Nabavi, Mahmood ;
Shoaei, Simin Dokht ;
Izadi, Hossein ;
Kashi, Amir Shahram Yousefi ;
Dehbaneh, Hadiseh Shabanpour ;
Taghizadeh-Hesary, Farzad .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (05) :1134-1139
[7]  
Anson BD, 2005, LANCET, V365, P682, DOI 10.1016/S0140-6736(05)70936-3
[8]   Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status [J].
Antinori, Spinello ;
Cossu, Maria Vittoria ;
Ridolfo, Anna Lisa ;
Rech, Roberto ;
Bonazzetti, Cecilia ;
Pagani, Gabriele ;
Gubertini, Guido ;
Coen, Massimo ;
Magni, Carlo ;
Castelli, Antonio ;
Borghi, Beatrice ;
Colombo, Riccardo ;
Giorgi, Riccardo ;
Angeli, Elena ;
Mileto, Davide ;
Milazzo, Laura ;
Vimercati, Stefania ;
Pellicciotta, Martina ;
Corbellino, Mario ;
Torre, Alessandro ;
Rusconi, Stefano ;
Oreni, Letizia ;
Gismondo, Maria Rita ;
Giacomelli, Andrea ;
Meroni, Luca ;
Rizzardini, Giuliano ;
Galli, Massimo .
PHARMACOLOGICAL RESEARCH, 2020, 158
[9]   Association between electrocardiographic features and mortality in COVID-19 patients [J].
Antwi-Amoabeng, Daniel ;
Beutler, Bryce D. ;
Singh, Sahajpreet ;
Taha, Moutaz ;
Ghuman, Jasmine ;
Hanfy, Ahmed ;
Manasewitsch, Nicholas T. ;
Ulanja, Mark B. ;
Ghuman, Joban ;
Awad, Munadel ;
Gullapalli, Nageshwara ;
Gbadebo, T. David .
ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2021,
[10]   Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation [J].
Aromolaran, Ademuyiwa S. ;
Srivastava, Ujala ;
Ali, Alessandra ;
Chahine, Mohamed ;
Lazaro, Deana ;
El-Sherif, Nabil ;
Capecchi, Pier Leopoldo ;
Laghi-Pasini, Franco ;
Lazzerini, Pietro Enea ;
Boutjdir, Mohamed .
PLOS ONE, 2018, 13 (12)
12345678910